Skip to main content
Clinical Trials/NCT05958108
NCT05958108Active, not recruitingPhase 3

Evaluation of SINERGIAPS, an Intervention to Improve Patient Safety in Primary Care Centers in Spain Based on Patients' Perceptions and Experiences. Hybrid Type I Clinical Trial

Fundació d'investigació Sanitària de les Illes Balears8 sites in 1 country110 target enrollmentStarted: September 1, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 3
Status
Active, not recruiting
Sponsor
Enrollment
110
Locations
8
Primary Endpoint
Rate of avoidable hospitalizations

Study Overview

Brief Summary

Aims: To evaluate the effectiveness of SinergiAPS (a patient-centered audit and feedback intervention) in reducing avoidable hospital admission, and; to explore the factors that may affect its implementation.

Design: 24-month, parallel, open-label, multicentre, pragmatic, hybrid type 1 randomized clinical trial.

Setting, sample, and randomization: 118 primary healthcare centers from multiple regions in Spain will be randomly assigned (ratio 1:1) to two groups (control and intervention). The intervention group will receive two audits (baseline and intermediate at 12 months). The audits will consist of the administration of the PREOS-PC questionnaire (a measure of patient-reported patient safety) to a sample of around 100 patients per center. The intervention group will receive reports on the results of both audits, along with resources aimed at facilitating the design and implementation of safety improvement plans. The intervention will be deployed through the SinergiAPS web tool, developed and validated in previous projects. The control group will have access to the intervention after the end of the clinical trial (waitlist).

Outcomes: Primary outcome: rate of avoidable hospitalizations (electronic health records). Secondary outcomes: patient-reported patient safety (PREOS-PC questionnaire); patient safety culture perceived by professionals (MOSPC questionnaire); adverse events experienced by healthcare professionals (ad hoc questionnaire); the number of safety improvement actions (ad hoc questionnaire). Outcome data will be collected at baseline and at 24 months follow-up.

Implementation evaluation: Drawing on the CFIR model, we will collect and analyze qualitative (30 individual interviews, implementation logbooks) and quantitative (questionnaires for professionals from intervention centers, level of use of the SinergiAPS web tool) data to examine the implementation of the intervention in the Spanish primary healthcare centers.

Detailed Description

GENERAL OBJECTIVE To evaluate the effectiveness and implementation of SinergiAPS, an intervention based on patient perceptions and experiences, aimed at improving patient safety in primary healthcare centers.

SPECIFIC OBJECTIVES

  • To evaluate, through a hybrid type I randomized clinical trial with a 24-month follow-up, the effectiveness of the SinergiAPS intervention in improving patient safety in primary healthcare centers by reducing avoidable hospitalizations (primary outcome variable), as well as increasing the safety culture, increasing the number of patient safety improvement actions in the centers, and increasing patient-perceived safety (secondary outcome variables).
  • To study the degree of usage of the SinergiAPS intervention in the primary healthcare centers allocated to the intervention group; as well as the contextual factors associated with its successful implementation.

METHODS Study design: Hybrid type 1 clinical trial, pragmatic, multicenter, open-label, with a 24-month follow-up. The primary healthcare centers will be randomly assigned to the intervention group (which will receive the SinergiAPS intervention - described below) and the control group (waitlist design: usual clinical practice during the 24-month follow-up, after which they will have access to the SinergiAPS intervention).

Description of SinergiAPS

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •In this study, we will apply specific criteria for 1) primary health care centers (unit of randomization and analysis), and 2) primary care professionals, as detailed below:
  • •Inclusion Criteria for primary care CENTRES: We will include public primary healthcare centers from any autonomous community in Spain that willingly agree to participate through informed consent signed by the manager of the center.

Exclusion Criteria

  • •for primary care CENTRES:
  • •Centers that exclusively provide specific services (such as pediatrics or women's health centers)
  • •Centers that have been established for less than 12 months at the time of recruitment
  • •Inclusion Criteria for primary care PROFESSIONALS: All professionals in primary care health centers meeting the criteria above described, including healthcare and non-healthcare professionals, who have been working at the center for at least 3 months will be invited to participate in the study.
  • •Exclusion Criteria for primary care PROFESSIONALS:
  • •professionals declining to complete the baseline questionnaires.
  • •professionals having been worked in the center for less than three months at the moment of recruitment

Arms & Interventions

Control group

No Intervention

Primary care centers allocated to the Control Group will continue with healthcare as usual. They will receive the intervention at the end of the trial, once all post-intervention data has been collected (waitlist approach). Although audits will be conducted in this group, the centers in this group will not have access to the feedback reports or any other information with the results from the audits.

SinergiAPS intervention group

Experimental

SinergiAPS is an assessment and monitoring tool designed to support primary healthcare centers to identify potential problems and areas for improvement related to patient safety based on information provided by their own patients. This intervention consists of three main elements:

  1. Patient safety audit of healthcare centers: Patient safety is evaluated from the perspective of patients using the validated PREOS-PC questionnaire.
  2. Feedback of results to healthcare centers: SinergiAPS automatically generates a report with the audit results. This feedback report is specific to each healthcare center and includes a comparison with other participating centers to facilitate benchmarking.
  3. Design of action plans: The centers design patient safety improvement plans based on the problems identified in their center's result report. For this purpose, the SinergiAPS web tool provides resources, training materials, and recommendations on how to improve patient safety in primary care.

Intervention: SinergiAPS intervention (Behavioral)

Outcomes

Primary Outcomes

Rate of avoidable hospitalizations

Time Frame: Baseline, and at 24 month follow-up

The rate of avoidable hospitalizations will be assessed based on the definition provided by the Agency for Health Research and Quality. Data for this assessment will be extracted from the Minimum Basic Data Set (CMBD) using predefined CIE-9 codes. The rate of avoidable hospitalizations will be calculated specifically for conditions such as asthma, chronic obstructive pulmonary disease, congestive heart failure, angina, and diabetes. For each participating healthcare center, we will obtain the total number of registered patients and the total number of avoidable hospitalizations recorded during the previous twelve months

Secondary Outcomes

  • Activation of healthcare centers (patient-reported mesure)(Baseline, and at 24 month follow-up)
  • Experiences of safety incidents (errors) (patient-reported mesure)(Baseline, and at 24 month follow-up)
  • Experience of harm (severity) (patient-reported mesure)(Baseline, and at 24 month follow-up)
  • Overall assessment of the center's safety level (patient-reported mesure)(Baseline, and at 24 month follow-up)
  • Adverse events experienced by healthcare professionals (self-reported by professinals at primary health care centres)(Baseline, and at 24 month follow-up)
  • Number of actions aimed at improving patient safety in the center in the last 12 months:(Baseline, and at 24 month follow-up)
  • Burden of harm (patient-reported mesure)(Baseline, and at 24 month follow-up)
  • Patient safety culture of healthcare professionals (self-reported by professinals at primary health care centres)(Baseline, and at 24 month follow-up)

Investigators

Sponsor
Fundació d'investigació Sanitària de les Illes Balears
Sponsor Class
Other Gov
Responsible Party
Sponsor

Study Sites (8)

Loading locations...

Similar Trials